For the fifth year in a row PARIS, FRANCE / ACCESSWIRE / May 22, 2024 / TISSIUM, a privately-owned medtech company developing biomorphic programmable polymers for tissue reconstruction, confirms its selection
TISSIUM, a privately-owned medical technology company developing biomorphic programmable polymers for atraumatic tissue repair, announced today the first clinical use of TISSIUM's Adhesive Hernia Repair System (the "ECLIPSIUM System") in patients undergoing laparoscopic ventral hernia repair as part of the ALPHA clinical study taking place in Belgium.
EQS-News: ABIVAX / Key word: Personnel
Abivax announces the appointment of June Lee, M.D. and Troy Ignelzi as Members of the Board of Directors
11.07.2023 /.
The award recognizes a significant capital market transaction in the biotech sector.
Abivax received the award for its oversubscribed EUR 130M cross-over financing at market price with top-tier US. | June 19, 2023